Is A Class-Wide Myocarditis Warning Coming For COVID-19 Vaccines?

Heart and COVID-19
The FDA is wondering whether myocarditis is a class-wide adverse event for COVID-19 vaccines. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet